Revenio Group Oyj (HEL: REG1V)

Market Cap	714.37M
Revenue (ttm)	102.49M
Net Income (ttm)	19.11M
Shares Out	26.60M
EPS (ttm)	0.72
PE Ratio	37.44
Forward PE	29.65
Dividend	0.38 (1.41%)
Ex-Dividend Date	n/a

Volume	43,262
Open	25.96
Previous Close	26.36
Day's Range	25.60 - 26.86
52-Week Range	23.36 - 35.84
Beta	1.37
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 13, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 207
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: REG1V

Financial Performance

In 2023, Revenio Group Oyj's revenue was 96.79 million, a decrease of -0.46% compared to the previous year's 97.23 million. Earnings were 19.11 million, a decrease of -12.15%.